Menu
Treatment Comparison

Supartz FX vs Synvisc-One

Supartz vs Synvisc-One: compare multi-injection series with single-shot HA. Schedule, molecular weight, cost, and best fit.

Side-by-Side Comparison

Injection Schedule

Supartz FX 3-5 weekly injections
Synvisc-One 1 single injection

Molecular Weight

Supartz FX Medium (620-1,170 kDa)
Synvisc-One Very high (6 million Da)

Cross-linked

Supartz FX No
Synvisc-One Yes (hylan G-F 20)

Volume per Treatment

Supartz FX 7.5-12.5 mL total
Synvisc-One 6 mL (single)

Source

Supartz FX Avian (rooster comb)
Synvisc-One Avian (rooster comb)

Manufacturer

Supartz FX Bioventus
Synvisc-One Sanofi

FDA Approval

Supartz FX 2001
Synvisc-One 2009

Self-Pay Cost

Supartz FX $600-$1,000
Synvisc-One $800-$1,200

Duration

Supartz FX Up to 6 months
Synvisc-One Up to 6 months

Medicare Coverage

Supartz FX Yes
Synvisc-One Yes

It Depends on Your Situation

Supartz FX delivers 2-4x more total HA volume at a lower drug cost. Synvisc-One provides the highest molecular weight of any product in a single convenient injection. Both are avian-derived with similar duration of relief.

Best for: Supartz FX for more total HA at lower cost; Synvisc-One for single-visit convenience with maximum molecular weight.

More HA or Fewer Visits? That Is the Question.

Supartz FX and Synvisc-One represent two very different treatment philosophies within the same category. Supartz FX delivers a higher total volume of HA over multiple visits. Synvisc-One provides the highest molecular weight available in a single visit. Both are avian-derived, both are Medicare-covered, and both target knee osteoarthritis pain.


Quick Comparison Table

FeatureSupartz FXSynvisc-One
ManufacturerBioventusSanofi
Injections needed3-5 weekly1
Volume per injection2.5 mL6 mL
Total volume7.5-12.5 mL6 mL
Molecular weight620-1,170 kDa6 million Da
Cross-linkedNoYes (hylan polymer)
SourceAvianAvian
Bird allergy safeNoNo
FDA approval20012009
HCPCS CodeJ7321J7325
DurationUp to 6 monthsUp to 6 months
Self-pay cost$600-$1,000$800-$1,200

What Is Supartz FX?

Supartz FX is a non-cross-linked, medium molecular weight sodium hyaluronate originally developed in Japan by Seikagaku Corporation. The current “FX” formulation offers physicians flexibility between a 3-injection and 5-injection protocol.

The Supartz FX Advantage: Volume

Supartz FX delivers significantly more total HA than Synvisc-One:

  • 3-injection protocol: 7.5 mL total (2.5 mL per injection x 3)
  • 5-injection protocol: 12.5 mL total (2.5 mL per injection x 5)
  • Synvisc-One: 6 mL total (single injection)

Some physicians believe that delivering more HA over time allows better joint coverage and more thorough lubrication. Others argue that molecular weight and cross-linking matter more than volume.

Additional Supartz FX Strengths

Lower cost - Drug cost is typically $200-400 less than Synvisc-One
Non-cross-linked - Natural HA may carry lower inflammatory risk
Flexible dosing - Doctor can choose 3 or 5 injections based on your needs

What Is Synvisc-One?

Synvisc-One contains hylan G-F 20, a cross-linked hyaluronic acid polymer from Sanofi. At approximately 6 million Daltons, it has the highest molecular weight of any HA product on the market.

The Synvisc-One Advantage: Convenience and MW

One visit, done - No weekly return appointments
Highest molecular weight - 6 million Da provides maximum theoretical cushioning
Most established single-shot - First single-injection HA, 15+ years of data
One copay - Single visit means one office visit fee

Head-to-Head: Volume vs. Molecular Weight

This comparison highlights the central debate in viscosupplementation: does more HA matter, or does higher molecular weight matter?

The Case for More Volume (Supartz FX)

  • Up to 12.5 mL total HA delivered
  • Multiple doses may provide more thorough joint coverage
  • Gradual delivery allows body to adapt
  • Non-cross-linked = more natural HA structure
  • Lower cost per mL of HA

The Case for Higher MW (Synvisc-One)

  • 6 million Da molecular weight (highest available)
  • Cross-linking creates more viscous gel
  • Single injection = maximum convenience
  • Hylan polymer designed to persist longer
  • Theoretical superior cushioning per mL

What the evidence says: Clinical trials have not proven that either approach is consistently superior. Both produce similar outcomes in terms of pain relief, function improvement, and duration of benefit.


Cost Analysis

FactorSupartz FX (3-shot)Supartz (5-shot)Synvisc-One
Drug cost$600-$800$800-$1,000$800-$1,200
Office copays$75-$150$125-$250$25-$50
Total (self-pay)$675-$950$925-$1,250$825-$1,250
Total (Medicare)$150-$300$200-$400$100-$250

Key finding: The 3-shot Supartz FX protocol is the most affordable option. Synvisc-One is comparable in total cost to the 5-shot Supartz protocol when copays are included.


Making Your Decision

Choose Supartz FX if:

  • You want more total HA volume delivered to the joint
  • Lower drug cost is important
  • You prefer non-cross-linked formulation
  • You can commit to 3-5 weekly visits
  • Your doctor recommends gradual delivery

Choose Synvisc-One if:

  • Single-visit convenience is a priority
  • You want the highest molecular weight available
  • Minimizing copays matters (one visit vs. multiple)
  • You or your doctor prefer the most established single-shot product
  • Transportation or scheduling makes repeat visits difficult

Frequently Asked Questions

Is Synvisc-One more effective because it has higher molecular weight?

Not necessarily. Clinical studies have not shown that higher molecular weight consistently produces better outcomes. Both products achieve similar pain relief and duration of benefit.

Can I switch from Supartz to Synvisc-One?

Yes. Switching between products is safe and common. If you have been getting Supartz series and want to try single-injection convenience, Synvisc-One is a reasonable option.

Do both require the same allergy screening?

Yes. Both are avian-derived and require screening for egg, chicken, and poultry allergies. If you have avian allergies, neither is safe. Consider Euflexxa or Durolane instead.

Which product do most doctors recommend?

This varies by practice. Some physicians prefer multi-injection protocols, while others favor single-injection convenience. The best product is the one your specific doctor has the most experience and success with.


The Bottom Line

Supartz FX delivers more HA at lower cost with a proven 25-year track record. Synvisc-One provides maximum molecular weight with maximum convenience.

Both treat knee OA effectively with similar outcomes and duration. Your choice comes down to:

  • More HA and lower cost = Supartz FX
  • Fewer visits and highest MW = Synvisc-One

Talk to your provider about which approach they recommend for your situation.

Find HA Injection Providers

Connect with specialists offering Supartz, Synvisc-One, and other knee OA treatments.

Imaging-Guided Medicare Accepted

Used to find providers in your area

Required to submit this form

Your information is secure. See our Privacy Policy and Terms of Service.

Thank You!

We've received your request. A provider specialist will contact you within 1-2 business days to help you find the right care.

What happens next?

  • 1 We'll verify your insurance coverage
  • 2 Match you with quality providers in your area
  • 3 Contact you to discuss your options

Questions? Browse our guides:

How to Choose a Provider

HA Treatment Comparisons

Get evidence-based comparisons of knee OA injection options.

You're in! Check your inbox.

Join 10,000+ readers. No spam.

Still Not Sure?

Take our quick assessment to find which treatment might be right for your specific situation.